Gujarat Exclusive > Gujarat news > Gujarat govt issues guidelines on Remdesivir use

Gujarat govt issues guidelines on Remdesivir use

0
593

Unable to meet the demand of Remdesivir—a crucial antiviral drug used for COVID-19 treatment, the Gujarat government has issued guidelines related to the jab that is in huge demand owing to the massive surge in hospitalisations and deaths due to the deadly virus.

The government has said that there is no evidence that suggests that Remdesivir can reduce the death rate due to COVID-19 or reduce the dependence of positive patients on ventilators. The government has also said that there is no evidence that suggests that the jab can reduce the number of days of hospitalisation.

The government has also clarified that there is uncertainty on whether Remdesivir has an impact on viral clearance. It has also been said that the jab should be administered only in serious patients and not for those who have mild symptoms.

When Remdesivir should be administered?

According to the government guideline, the jab should be administered only in serious patients who have high-grade fever for the past 3-4 days, the presence of C-reactive protein in blood has increased and if oxygen level has declined to 93 per cent.

Also Read: Gujarat: 10,340 COVID-19 cases, 110 deaths in a day

The government guideline also suggests that the jab should be administered if the patient is feeling extreme weakness and breathlessness; if the patient is 50 years old and due to COVID, CRP, d-Dimer and Ferritin have increased; and ground-glass opacity in chest X-ray.

The government has also suggested that the jab should be administered after consultation with an infectious disease specialist, pulmonologist, physician or child specialist.

What doctors say

Renowned heart specialist Tejas Patel, in the government guideline, said that people should not be afraid of COVID-19 and should not unnecessarily demand a Remdesivir injection.

Infectious disease specialist Atul Patel said that the Remdesivir jab is not a lifesaving drug and there is no need to create hype regarding it.  

 

To read the latest news in Gujarati click here